Join our Community
Support ToI and remove all ads
Learn more
×

immune system

Elderly people work out with wooden dumb-bells in the grounds of a temple in Tokyo on September 17, 2012, to celebrate Japan's Respect-for-the-Aged-Day. (YOSHIKAZU TSUNO / AFP)
December 2, 2025, 7:23 am
Medical Holy Grail: Israeli researchers isolate elusive cells that may slow down aging
In peer-reviewed study, Prof. Alon Monsonego’s lab finds that ‘T helper’ blood cells, abundant in ‘super-centenarians’ in high-life-expectancy zone in Japan, may point the way to longevity
By Diana Bletter
Israel Prize recipient Prof. Michal Schwartz blazes a trail toward anti-aging treatment through immune therapy (Courtesy of Weizmann Institute of Science)
January 14, 2025, 3:05 pm
Israeli scientist in peer-reviewed study: Immunotherapy treatment could slow aging process
Israel Prize winner Prof. Michal Schwartz says her team’s work fighting Alzheimer’s can lead to treatments that boost immune system to slow down deterioration in brain – and body
By Diana Bletter
Illustrative image: A cancer patient receives immunotherapy (Elaine Thompson/AP Photo)
June 7, 2023, 1:03 pm
New Israeli technology improves prediction of patient response to immunotherapy
Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval
By Renee Ghert-Zand
Israel Prize recipient Prof. Michal Schwartz blazes a trail toward anti-aging treatment through immune therapy (Courtesy of Weizmann Institute of Science)
April 26, 2023, 6:38 am
For scientist Michal Schwartz, Israel Prize is rewarding milestone in ongoing journey
Weizmann Institute neuroimmunologist bucked convention to prove that brain is not isolated from immune system, leading to possible therapies to treat Alzheimer’s and other diseases
By Renee Ghert-Zand
This undated, colorized electron microscope image made available by the US National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, indicated in yellow, emerging from the surface of cells, indicated in blue/pink, cultured in the lab. (NIAID-RML via AP, File)
April 22, 2022, 2:38 am
Study shows immunocompromised UK patient had COVID-19 for 505 days straight
Researchers say longest reported infection underscores importance of protecting vulnerable people from coronavirus, with virus found to mutate during persistent infections
By laura ungar
MeMed Diagnostics founders Dr. Kfir Oved and Dr. Eran Eden. (Courtesy)
January 10, 2022, 2:21 pm
Medical tech firm MeMed nabs $93m investment to decode body’s immune responses
Company’s BV blood test to distinguish between bacterial and viral infections recently cleared by FDA; investors include Hong Kong’s Horizons Ventures
By Ricky Ben-David
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.